發(fā)布時(shí)間：2018-02-10 22:03

  本文關(guān)鍵詞： 特發(fā)性膜性腎病 宣通三焦、活血通絡(luò) 中西醫(yī)結(jié)合 臨床研究 臨床療效　出處：《河北醫(yī)科大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:本課題通過對(duì)特發(fā)性膜性腎病的臨床研究,以觀察宣通三焦、活血通絡(luò)方治療特發(fā)性膜性腎病的療效及安全性,為臨床推廣應(yīng)用提供數(shù)據(jù)支持及科學(xué)依據(jù),并論證和探討特發(fā)膜性腎病所存在的脾腎陽(yáng)虛、水濕血瘀、三焦氣化不利的基本病機(jī),從而為中醫(yī)辨證論治提供新思路。方法:將符合入選標(biāo)準(zhǔn)的62例特發(fā)性膜性腎病患者,采用隨機(jī)數(shù)字表法分為試驗(yàn)組32例和對(duì)照組30例。對(duì)照組予激素聯(lián)合環(huán)磷酰胺治療,同時(shí)予以常規(guī)對(duì)癥治療,囑患者休息、低鹽低脂優(yōu)質(zhì)蛋白飲食以及利尿、降脂、降壓、抗凝等對(duì)癥治療。試驗(yàn)組在對(duì)照組治療基礎(chǔ)上,加服宣通三焦、活血通絡(luò)方,并隨證加減。觀察對(duì)比兩組治療前、治療3個(gè)月、治療6個(gè)月的各項(xiàng)療效指標(biāo)。結(jié)果:共有59例患者完成6個(gè)月觀察,其中試驗(yàn)組30例,對(duì)照組29例。兩組患者治療前24小時(shí)尿蛋白定量比較無(wú)統(tǒng)計(jì)學(xué)差異(P(29)0.05),具有可比性,治療3個(gè)月與治療前比較,兩組患者24小時(shí)尿蛋白均顯著減少(P(27)0.01),且試驗(yàn)組療效優(yōu)于對(duì)照組(P(27)0.05),治療6個(gè)月與治療前比較,兩組患者24小時(shí)尿蛋白均顯著減少(P(27)0.01),且試驗(yàn)組療效優(yōu)于對(duì)照組(P(27)0.01);兩組患者治療前總蛋白、白蛋白比較無(wú)統(tǒng)計(jì)學(xué)差異(P(29)0.05),具有可比性,治療3個(gè)月與治療前比較,兩組患者總蛋白、白蛋白均顯著升高(P(27)0.01),兩組比較無(wú)明顯差異(P(29)0.05),治療6個(gè)月與治療前比較,兩組患者總蛋白、白蛋白均明顯升高(P(27)0.01),且試驗(yàn)組療效優(yōu)于對(duì)照組(P(27)0.01);兩組患者治療前總膽固醇、甘油三酯、低密度脂蛋白膽固醇比較無(wú)統(tǒng)計(jì)學(xué)差異(P(29)0.05),具有可比性,治療3個(gè)月與治療前比較,試驗(yàn)組總膽固醇顯著降低(P(27)0.01),甘油三酯、低密度脂蛋白膽固醇無(wú)顯著變化(P(29)0.05),對(duì)照組總膽固醇、甘油三酯、低密度脂蛋白膽固醇無(wú)顯著變化(P(29)0.05),且兩組比較無(wú)明顯差異(P(29)0.05),治療6個(gè)月與治療前比較,兩組患者總膽固醇、甘油三酯、低密度脂蛋白膽固醇均顯著降低(P(27)0.01),且試驗(yàn)組療效優(yōu)于對(duì)照組(P(27)0.05,P(27)0.01);兩組患者治療前、治療3個(gè)月、治療6個(gè)月血肌酐、尿素氮、尿酸均無(wú)明顯差異(P(29)0.05);治療后兩組患者生命體征及血、尿、便常規(guī)加潛血、肝功能、ECG及膽、脾、胰B超均未發(fā)現(xiàn)明顯異常、治療過程中無(wú)不良反應(yīng)發(fā)生;試驗(yàn)組中醫(yī)癥候療效及西醫(yī)綜合療效優(yōu)于對(duì)照組(P0.05,P(27)0.01)。結(jié)論:宣通三焦、活血通絡(luò)方治療特發(fā)性膜性腎病有較好的療效,具有降低尿蛋白、升高血漿蛋白、調(diào)節(jié)血脂的作用,且有一定的保護(hù)腎功能作用,安全可靠,中醫(yī)癥候療效及西醫(yī)綜合療效突出,且隨療程延長(zhǎng)療效逐漸明顯。
[Abstract]:Objective: to observe the efficacy and safety of Xuantong Sanjiao and Huoxue Tongluo decoction in the treatment of idiopathic membranous nephropathy through the clinical study of idiopathic membranous nephropathy, and to provide data support and scientific basis for clinical application. The basic pathogenesis of idiopathic membranous nephropathy such as deficiency of spleen and kidney yang, water dampness and blood stasis, and unfavorable gasification of three Jiao were demonstrated and discussed. Methods: 62 patients with idiopathic membranous nephropathy who met the inclusion criteria were selected. The control group was treated with hormone combined with cyclophosphamide, the control group was treated with routine therapy, the patients were told to rest, low-salt and low-fat high quality protein diet, diuretic, lipid-lowering, hypotensive, diuretic, lipid-lowering and hypotensive diet. The experimental group was treated with Xuantong Sanjiao, Huoxue Tongluo recipe, and the syndrome was added and subtracted. Before the treatment, the two groups were treated for 3 months. Results: a total of 59 patients were observed for 6 months, 30 in the experimental group and 29 in the control group. There was no significant difference in urinary protein between the two groups at 24 hours before treatment. After 3 months of treatment, the urine protein of 24 hours in both groups was significantly decreased compared with that before treatment, and the curative effect of the trial group was better than that of the control group, and compared with that of the control group at 6 months. The 24 hour urine protein of the two groups was significantly reduced, and the curative effect of the experimental group was better than that of the control group. There was no significant difference in the total protein and albumin between the two groups before treatment, and there was no statistical difference between the two groups. The total protein of the two groups was comparable after 3 months of treatment compared with that before treatment, and the total protein of the two groups was higher than that of the control group. There was no significant difference between the two groups. The total protein and albumin of the two groups were significantly higher than those of the control group after 6 months of treatment, and the curative effect of the test group was better than that of the control group. The total cholesterol and triglyceride of the two groups before treatment were higher than those of the control group, and there was no significant difference between the two groups in total cholesterol and triglyceride before treatment, and the effect of the test group was better than that of the control group, and the effect of the two groups was better than that of the control group. There was no significant difference in low density lipoprotein cholesterol (LDL-C). There was no significant difference in low density lipoprotein cholesterol (LDL-C). Compared with before treatment for 3 months, the total cholesterol of the trial group was significantly lower than that of the control group, and the total cholesterol of the trial group was significantly lower than that of the control group. There was no significant change in the level of triglyceride and low density lipoprotein cholesterol. There was no significant change in triglyceride, low density lipoprotein cholesterol, and there was no significant difference between the two groups. After 6 months of treatment, total cholesterol, triglyceride and triglyceride were compared between the two groups. Low density lipoprotein cholesterol (LDL-C) was significantly decreased in both groups, and the curative effect of the trial group was better than that of the control group. There was no significant difference in serum creatinine, urea nitrogen and uric acid between the two groups before and after treatment for 3 months and 6 months, and there was no significant difference in vital signs and blood between the two groups after treatment. Urine, routine addition of occult blood, liver function, ECG, bile, spleen, pancreas B ultrasound did not find any obvious abnormalities, no adverse reactions occurred in the course of treatment, the effect of traditional Chinese medicine and western medicine in the experimental group was better than that in the control group (P0.05P0. 05, P0. 05, P0. 27 and 0. 01). Conclusion: Xuantong Sanjiao, Xuan Tong San Jiao, is better than the control group. Huoxue Tongluo recipe has a good effect in treating idiopathic membranous nephropathy. It can reduce urine protein, increase plasma protein, regulate blood lipid, protect renal function, and is safe and reliable. The curative effect of TCM symptom and western medicine is outstanding, and the curative effect is obvious with the course of treatment.
【學(xué)位授予單位】：河北醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R277.5

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 鄭曉珂;于洋;周靜;吳廣操;王小蘭;牛艷;黃巖杰;匡海學(xué);馮衛(wèi)生;;白術(shù)各化學(xué)拆分組分及其配伍對(duì)大鼠腎病綜合征的影響[J];中藥新藥與臨床藥理;2016年04期

2 王曉紅;馬紅珍;;“久病入絡(luò)”理論與膜性腎病的中醫(yī)治療[J];黑龍江中醫(yī)藥;2016年03期

3 江峽;;雷公藤多苷和小劑量激素聯(lián)合治療特發(fā)性膜性腎病的有效性及可行性分析[J];中國(guó)中西醫(yī)結(jié)合腎病雜志;2015年01期

4 楊永超;劉曉春;馬寶梅;馬浩;王春麗;;葉傳蕙教授治療特發(fā)性膜性腎病經(jīng)驗(yàn)[J];陜西中醫(yī);2015年01期

5 肖玉竹;;黃芪注射液聯(lián)合六味地黃丸治療100例腎病綜合征的近期臨床療效[J];內(nèi)蒙古中醫(yī)藥;2014年27期

6 錢虹;楊鈞杰;潘定一;唐文濤;許可佳;齊敏友;;淫羊藿總黃酮對(duì)實(shí)驗(yàn)性糖尿病大鼠腎臟保護(hù)作用[J];中國(guó)應(yīng)用生理學(xué)雜志;2014年04期

7 張磊;張勝容;;中醫(yī)藥治療Ⅰ-Ⅱ期特發(fā)性膜性腎病臨床療效分析[J];北京中醫(yī)藥;2014年02期

8 崔嶺;高海燕;焦亞莉;;百令膠囊聯(lián)合厄貝沙坦片治療膜性腎病38例臨床觀察及對(duì)免疫功能的影響[J];河北中醫(yī);2013年10期

9 朱蕓蕓;陳欽;鐘瑜;魯盈;徐再春;胡崗;;水蛭素對(duì)特發(fā)性膜性腎病足細(xì)胞nephrin的影響[J];中華中醫(yī)藥學(xué)刊;2013年07期

10 許源;宿樹蘭;王團(tuán)結(jié);段金廒;王振中;;桂枝的化學(xué)成分與藥理活性研究進(jìn)展[J];中藥材;2013年04期

相關(guān)會(huì)議論文 前1條

1 湯絢麗;魯盈;朱曉玲;胡云琴;閔曼;王永鈞;;IgG亞型在鑒別膜性腎病病因中的意義[A];第十一屆全國(guó)中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2010年

相關(guān)博士學(xué)位論文 前1條

1 李黎莉;益氣養(yǎng)陰活血通絡(luò)方對(duì)糖尿病腎病大鼠足細(xì)胞的影響[D];河北醫(yī)科大學(xué);2012年

相關(guān)碩士學(xué)位論文 前1條

1 王鑫;呂仁和教授臨證經(jīng)驗(yàn)及學(xué)術(shù)思想淺析[D];北京中醫(yī)藥大學(xué);2013年

，

本文編號(hào)：1501540